TP53 and head and neck squamous cell carcinoma: In contrast, low-risk p53 mutations appeared to have retained some p53 function since patients with HNSCC containing these alterations had similar survival outcomes to wildtype p53 and cells had an intermediate level of invasiveness and tumorigenicity [12].